Search by Title Article Topic - Any -AdvocacyAnnual Scientific MeetingAwardsBoard Certification ReviewCertificationClinical DocumentClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHF Research FoundationHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterIn The NewsIndustryJournal of Cardiac FailureLeadershipMembershipMentorshipNursingPartnersPatient ResourcePatient StoryPodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaStatementSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News May 18 2023 | New Study Demonstrates Clinical Utility of Daxor’s Blood Volume (BVA-100®) Diagnostic in Heart Failure Outcomes Industry News In The News Industry Read More May 12 2023 | Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-4021586 Industry News In The News Industry Read More May 9 2023 | FARXIGA extended in the US to reduce risk of cardiovascular death and hospitalization for heart failure to a broader range of patients Industry News Industry Read More Apr 26 2023 | Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for CAMZYOS® (mavacamten) for the Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy (HCM) Industry News In The News Industry Read More Apr 20 2023 | New Studies Presented at the 43rd International Society for Heart and Lung Transplant Validate the Applicability of the BVA-100® Blood Test for Patients with Advanced Heart Failure Industry News In The News Industry Read More Pagination First page « First Previous page ‹ Previous … Page 3 Page 4 Page 5 Page 6 Current page 7 Page 8 Page 9 Page 10 Page 11 … Next page Next › Last page Last »
May 18 2023 | New Study Demonstrates Clinical Utility of Daxor’s Blood Volume (BVA-100®) Diagnostic in Heart Failure Outcomes Industry News In The News Industry Read More
May 12 2023 | Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-4021586 Industry News In The News Industry Read More
May 9 2023 | FARXIGA extended in the US to reduce risk of cardiovascular death and hospitalization for heart failure to a broader range of patients Industry News Industry Read More
Apr 26 2023 | Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for CAMZYOS® (mavacamten) for the Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy (HCM) Industry News In The News Industry Read More
Apr 20 2023 | New Studies Presented at the 43rd International Society for Heart and Lung Transplant Validate the Applicability of the BVA-100® Blood Test for Patients with Advanced Heart Failure Industry News In The News Industry Read More
